EXECUTIVES

ITM Appoints Dr. Celine Wilke Chief Medical Officer

“Celine brings a wealth of experience in advancing radiopharmaceutical precision oncology treatments from early development through to regulatory approval. As she steps into the leadership of our medical team, her expertise will be instrumental in progressing our pipeline and delivering new treatment options for patients,” said Dr. Andrew Cavey, Chief Executive Officer of ITM.

Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair

Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.

Olga Uspenskaya-Cadoz Appointed Chief Medical Officer of VectorY Therapeutics

Dr. Uspenskaya-Cadoz brings two decades of experience in neurology, gene therapy, and clinical development, enhancing VectorY’s leadership in developing transformative treatments for neurodegenerative conditions.

Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief | The Appointment of Dr Matthew Hepburn to Expand Panther’s Leadership For...

In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first commercial product to customers within the next two years.

Michael Andersen Joins Vektor Medical as Vice President, Quality Assurance and Regulatory Affairs

Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth.

Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics

"I am honored to lead Nimbus at this pivotal time in the company's evolution," said Abbas Kazimi. "Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I'm particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”

Mirva Ekman Appointed Quality Director & Member of the Management Team at Bioretec

Mirva Ekman over 20 years of experience in quality and regulatory leadership.

Kristen Cardillo Takes Charge as Senior VP Chief Communications Officer at Zimmer Biomet

Kristen Cardillo will join the Company on March 10, 2025, to lead Zimmer Biomet's global communications strategy, enhancing engagement with key stakeholders and amplifying the Company's position as a leader in MedTech.

Jupiter Endovascular Appoints Fred Ong as CFO

Fred Ong brings more than 30 years of experience in building and growing venture capital-backed healthcare technology companies to his role at Jupiter Endovascular, including playing key roles in fundraising, corporate strategy, operational growth, revenue scale, and M&A exits.
Medical Device News Magazinespot_img